Advanced Enzyme Technologies Ltd's Q4FY25 Quarter Results
- 14 May 2025
Result Summary
- Advanced Enzyme Technologies Ltd reported a 5.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 11.7%.
- Its expenses for the quarter were down by 9.0% QoQ and up 8.6% YoY.
- The net profit decreased 23.2% QoQ and decreased 7.0% YoY.
- The earnings per share (EPS) of Advanced Enzyme Technologies Ltd stood at 2.5 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 167.31 | 176.80 | 149.79 | -5.4% | 11.7% |
Total Expenses | 112.58 | 123.77 | 103.62 | -9.0% | 8.6% |
Profit Before Tax | 39.61 | 53.02 | 42.10 | -25.3% | -5.9% |
Tax | 9.74 | 14.14 | 9.99 | -31.1% | -2.5% |
Profit After Tax | 29.87 | 38.88 | 32.11 | -23.2% | -7.0% |
Earnings Per Share | 2.50 | 3.40 | 2.90 | -26.5% | -13.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Advanced Enzyme Technologies Ltd is a company known for its focus on enzyme research and biocatalysts. The company is involved in the production and distribution of enzyme products that serve various industries, including pharmaceuticals, food and beverages, textiles, and animal nutrition. Enzymes are proteins that act as catalysts and are essential for numerous industrial processes, making them a critical component in enhancing product quality and efficiency. As of the data available, there are no specific recent major developments provided for the company. However, given the nature of its business, the company is likely engaged in ongoing research and development activities to innovate and improve its enzyme offerings.
Revenue
In the fourth quarter of fiscal year 2025 (Q4FY25), Advanced Enzyme Technologies Ltd reported a total income of ₹167.31 crores. This represents a decrease of 5.4% on a quarter-over-quarter (QoQ) basis compared to the third quarter of fiscal year 2025 (Q3FY25), where the total income was ₹176.80 crores. However, there is an increase of 11.7% year-over-year (YoY) compared to the fourth quarter of fiscal year 2024 (Q4FY24), when the total income stood at ₹149.79 crores. These figures highlight the fluctuations in revenue within the specified periods.
Profitability
The company recorded a profit before tax of ₹39.61 crores in Q4FY25, which is a decline of 25.3% QoQ from ₹53.02 crores in Q3FY25. Year-over-year, this figure also decreased by 5.9% from ₹42.10 crores in Q4FY24. The tax expense for Q4FY25 was ₹9.74 crores, showing a 31.1% QoQ decrease from ₹14.14 crores in Q3FY25 and a 2.5% YoY decrease from ₹9.99 crores in Q4FY24. Consequently, the profit after tax for Q4FY25 was ₹29.87 crores, down 23.2% QoQ from ₹38.88 crores in Q3FY25 and down 7.0% YoY from ₹32.11 crores in Q4FY24. Earnings per share (EPS) for Q4FY25 was reported at ₹2.50, which is a decline of 26.5% QoQ from ₹3.40 in the preceding quarter and a 13.8% decrease YoY from ₹2.90 in the same quarter of the previous year.
Operating Metrics
Total expenses for Advanced Enzyme Technologies Ltd in Q4FY25 amounted to ₹112.58 crores, which is a decrease of 9.0% QoQ from ₹123.77 crores in Q3FY25. On a YoY basis, total expenses increased by 8.6% from ₹103.62 crores in Q4FY24. The company's operational efficiency can be further analyzed by calculating the profit margins and other financial ratios; however, such calculations require additional data not provided in the current dataset, such as total assets and liabilities for ratios like P/E ratio or current ratio. The trends in expenses and income reflect the company's operational adjustments over the quarters and year.
